Dr. Gary S. Leiserowitz, MD

Dr. Leiserowitz practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Leiserowitz's NPI, 1871575142, was assigned on November 14, 2005. Dr. Leiserowitz graduated from Carver College of Medicine in 1981. Dr. Leiserowitz holds California license C407800.

Dr. Leiserowitz's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Leiserowitz's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Leiserowitz is also affiliated with Marshall Medical. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Leiserowitz to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leiserowitz practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Leiserowitz's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Leiserowitz is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Leiserowitz's licenses on file in 3 states: California, Minnesota and Iowa.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Leiserowitz treats.

CMS data shows 141 Medicare services from Dr. Leiserowitz across 5 procedure codes in 2024, for 111 Medicare patients. Medicare paid $17,171 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Dr. Leiserowitz in 2024. The largest group is 65 to 74, with 55 patients. 74% of them have high blood pressure, and 70% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leiserowitz's median patient age at 61, with 100% women.

In 2024, Dr. Leiserowitz wrote 43 Medicare Part D claims for 14 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $81 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Leiserowitz for performance year 2024, reported as part of a group. Dr. Leiserowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leiserowitz as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 43 papers to Dr. Leiserowitz, published from 2005 to 2023. 2016 was the busiest year, with 3. The most frequent topics are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial and Polysaccharides. Dr. Leiserowitz has published most often in Gynecol Oncol. Dr. Leiserowitz's most frequent co-authors are Rebecca Ann Brooks, MD, William A. Cliby, MD and Jyoti S. Mayadev, MD.

Dmand AI links Dr. Leiserowitz to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Brenner Tumor, Carcinoma, Ovarian Epithelial and Uterine Cervical Neoplasms.

CMS Open Payments shows 7 general payments to Dr. Leiserowitz from 5 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $245.

Dmand AI lists 5 awards for Dr. Leiserowitz, most recently Top Docs in 2022.

Dr. Leiserowitz graduated from Carver College of Medicine in 1981. Dr. Leiserowitz is a member of American College of Obstetricians and Gynecologists, Society of Gynecologic Oncology and Western Association of Gynecologic Oncology.

Dr. Leiserowitz is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.